Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Facilities costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept amrx:FacilitiesCosts.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s affordable medicines — facilities costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s affordable medicines — facilities costs?
- Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — facilities costs of $1.49M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s affordable medicines — facilities costs changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s affordable medicines — facilities costs decreased by 8.8% year-over-year, from $1.63M to $1.49M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s affordable medicines — facilities costs?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s affordable medicines — facilities costs has grown at a -10.1% compound annual growth rate (CAGR), from $9.4M to $6.83M.
- What does affordable medicines — facilities costs mean?
- Includes fixed and variable costs related to the maintenance, rent, and operation of manufacturing and administrative facilities. This metric provides insight into the overhead burden required to sustain the segment's physical infrastructure.